{"organizations": [], "uuid": "e1b344b5aa6e629ebf50d5406a45cb9b850287a5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180411.html", "section_title": "Archive News &amp; Video for Wednesday, 11 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-inovio-awarded-up-to-56-million-fr/brief-inovio-awarded-up-to-56-million-from-cepito-advance-dna-vaccines-against-lassa-fever-and-mers-idUSFWN1RO0PG", "country": "US", "domain_rank": 408, "title": "BRIEF-Inovio Awarded Up To $56 Million From Cepi To Advance Dna Vaccines Against Lassa Fever And Mers", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.826, "site_type": "news", "published": "2018-04-11T20:09:00.000+03:00", "replies_count": 0, "uuid": "e1b344b5aa6e629ebf50d5406a45cb9b850287a5"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-inovio-awarded-up-to-56-million-fr/brief-inovio-awarded-up-to-56-million-from-cepito-advance-dna-vaccines-against-lassa-fever-and-mers-idUSFWN1RO0PG", "ord_in_thread": 0, "title": "BRIEF-Inovio Awarded Up To $56 Million From Cepi To Advance Dna Vaccines Against Lassa Fever And Mers", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "inovio pharmaceuticals inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 11 (Reuters) - Inovio Pharmaceuticals Inc:\n* INOVIO AWARDED UP TO $56 MILLION FROM CEPI TO ADVANCE DNA VACCINES AGAINST LASSA FEVER AND MERS\n* ANNOUNCED PARTNERSHIP UNDER WHICH CO WILL DEVELOP VACCINE CANDIDATES AGAINST LASSA FEVER AND MIDDLE EAST RESPIRATORY SYNDROME\n* 4700 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-11T20:09:00.000+03:00", "crawled": "2018-04-12T13:48:11.003+03:00", "highlightTitle": ""}